Messino Cancer Centers Strengthens Commitment to Patient Care with New Physician

June 3, 2024


Board-certified physician Charles Wendling, Jr., MD, joins the physician team.


ASHEVILLE, N.C., June 3, 2024 – Community oncology practice Messino Cancer Centers, a partner practice of American Oncology Network (AON) (Nasdaq: AONC), is pleased to welcome Board-certified physician Charles Wendling, Jr., MD, to its physician care team. Dr. Wendling is available to see new and existing patients at the Asheville clinic.

Image Charles WendlingDr. Wendling is Board-certified in internal medicine, hematology and medical oncology. He received his medical degree from Louisiana State University School of Medicine in Shreveport and completed an internship and residency at Creighton University Medical Center. He then finished a hematology-oncology fellowship at Louisiana State University Health Sciences Center.

Dr. Wendling has been a practicing physician for over 25 years, specializing in hematology and medical oncology for over 15 years. He has experience treating a wide range of cancer and blood disorders; however, he is focused on cancerous and non-cancerous hematologic conditions.

“I am excited to join the physician team at Messino Cancer Centers,” said Dr. Wendling. “In exploring the practice, I quickly learned that Messino’s goals closely aligned with my patient care goals, making it an easy decision to join the team. Community oncology practices are critical to the health and well-being of its residents. Cancer clinics like Messino’s give patients access to high-quality care, services and therapies. I am passionate about ensuring accessible cancer care and believe that I will be able to have a greater impact in the community setting alongside the other Messino physicians.”

“We are honored to welcome Dr. Wendling to Messino Cancer Centers,” said Christopher Chay, MD, Board-certified medical oncologist at Messino. “He brings a wealth of knowledge and experience to our practice that will complement our already-established expertise and care. We eagerly look forward to working with him to continue delivering the best possible patient care.”

“On behalf of AON, I am excited to welcome Dr. Wendling to Messino Cancer Centers and the network,” said Stephen “Fred” Divers, MD, AON’s chief medical officer. “He has an impressive background that will undoubtedly be valuable to patients. Additionally, his commitment to community oncology and elevating the care provided in these settings match AON’s mission, vision and patient-first care approach. We are confident that Dr. Wendling will be an asset to the team.”

For more information about AON, visit For more information about Messino Cancer Centers, visit


About American Oncology Network
American Oncology Network (AON) (Nasdaq: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 240 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. Learn more at

About Messino Cancer Centers
Messino Cancer Centers provides treatment for adult patients diagnosed with all types of cancer and blood disorders. Messino Cancer Centers is grounded in the Western North Carolina region and devoted to providing personalized care of the highest quality to patients in community settings, close to where they live and work and where their loved ones are close by. We are proud of our 30-year history of providing the highest quality cancer treatment that is based on research and focused on the whole person. Learn more at

Contact for more information:
Caroline Hewitt, Vice President of Marketing
American Oncology Network